|
|
Blood, 15 March 2004, Vol. 103, No. 6, pp. 2205-2213.
Prepublished online as a Blood First Edition Paper on November 20, 2003; DOI 10.1182/blood-2003-08-2928.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Migration of V 1 and V 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1infected patients: competition by HIV-1 Tat
Alessandro Poggi,
Roberta Carosio,
Daniela Fenoglio,
Sabrina Brenci,
Giuseppe Murdaca,
Maurizio Setti,
Francesco Indiveri,
Silvia Scabini,
Elisabetta Ferrero, and
Maria Raffaella Zocchi
From the Laboratory of Immunology, National Institute for Cancer Research, Genoa, Italy; CEBR and Department of Internal Medicine, DIMI, University of Genoa, Italy; and Laboratory of Tumor Immunology, Scientific Institute San Raffaele, Milan, Italy.
We show that HIV-1infected patients have increased concentrations of circulating V 1 T cells (2.2%-9.0% of T lymphocytes; healthy donors, 1.0%-2%) and, in some instances, V 2 T cells (3.5%-4.8% vs 2.0%-3.3%). In these patients, both V 1 and V 2 T cells are CXCR3+CXCR4+, whereas in healthy donors CXCR4 was preferentially expressed on V 1 T lymphocytes.  T cells transmigrated across endothelial monolayers, in response to interferon- inducing protein-10 (IP-10/CXCL10), stromal cellderived factor-1 (SDF-1/CXCL12), or both, according to the expression of the specific receptors CXCR3 and CXCR4. Interestingly, 6Ckine/SLC/CCL21 was more effective than IP-10/CXCL10 on V 1 CXCR3+ cells, whereas V 2 CXCR3+ cells were driven more efficiently by IP-10/CXCL10. IP-10/CXCL10 and SDF-1/CXCL12induced transmigration was dependent on phosphoinositide-3 kinase (PI-3K), as demonstrated by the use of the specific blockers wortmannin and LY294002 and by the activation of the downstream serine kinase Akt/PKB on ligation of CXCR3 and CXCR4. Occupancy of CXCR3, but not of CXCR4, led to CAMKII activation; accordingly, the CAMKII inhibitors KN62 and KN93 decreased IP-10/CXCL10 but not SDF-1/CXCL12driven transmigration. Finally, HIV-1 Tat, which is present in the serum of HIV-1infected patients, interferes with the chemotactic activity of these chemokines because of the cysteine-rich domain of the protein, which contains CXC and CC chemokinelike sequences.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. A. Kosub, G. Lehrman, J. M. Milush, D. Zhou, E. Chacko, A. Leone, S. Gordon, G. Silvestri, J. G. Else, P. Keiser, et al.
Gamma/Delta T-Cell Functional Responses Differ after Pathogenic Human Immunodeficiency Virus and Nonpathogenic Simian Immunodeficiency Virus Infections
J. Virol.,
February 1, 2008;
82(3):
1155 - 1165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kittiworakarn, A. Lecoq, G. Moine, R. Thai, E. Lajeunesse, P. Drevet, C. Vidaud, A. Menez, and M. Leonetti
HIV-1 Tat Raises an Adjuvant-free Humoral Immune Response Controlled by Its Core Region and Its Ability to Form Cysteine-mediated Oligomers
J. Biol. Chem.,
February 10, 2006;
281(6):
3105 - 3115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Zocchi, P. Contini, M. Alfano, and A. Poggi
Pertussis Toxin (PTX) B Subunit and the Nontoxic PTX Mutant PT9K/129G Inhibit Tat-Induced TGF-{beta} Production by NK Cells and TGF-{beta}-Mediated NK Cell Apoptosis
J. Immunol.,
May 15, 2005;
174(10):
6054 - 6061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Deng, T. A. Moore, M. W. Newstead, X. Zeng, A. M. Krieg, and T. J. Standiford
CpG Oligodeoxynucleotides Stimulate Protective Innate Immunity against Pulmonary Klebsiella Infection
J. Immunol.,
October 15, 2004;
173(8):
5148 - 5155.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |